Evidence map›Paper›PMID 39234577›Full record

ArticleF1000Research2021

Design and prototype of TOMO: an app for improving drug resistant TB treatment adherence.

Anis Fuad, Guntur Budi Herwanto, Ariani Arista Putri Pertiwi, Siska Dian Wahyuningtias, Harsini Harsini, Ahmad Watsiq Maula, Diyah Utami Kusumaning Putri, Ari Probandari, Riris Andono Ahmad

Abstract read
In one paragraph

Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anis FuadDepartment of Biostatistics, Epidemiology and Population Health, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.ORCID https://orcid.org/0000-0003-2303-5903
Guntur Budi HerwantoDepartment of Computer Sciences and Electronics, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, 55284, Indonesia.
Ariani Arista Putri PertiwiDepartment of Basic and Emergency Nursing, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.ORCID https://orcid.org/0000-0001-6439-2304
Siska Dian WahyuningtiasCenter for Tropical Medicine, Faculty of Medicine, Public Health and Nursing; Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.
Harsini HarsiniDepartment of Pulmonology, Dr. Moewardi General Hospital, Surakarta, 57126, Indonesia.
Ahmad Watsiq MaulaDepartment of Biostatistics, Epidemiology and Population Health, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.
Diyah Utami Kusumaning PutriDepartment of Computer Sciences and Electronics, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, 55284, Indonesia.
Ari ProbandariCenter for Tropical Medicine, Faculty of Medicine, Public Health and Nursing; Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.
Riris Andono AhmadDepartment of Biostatistics, Epidemiology and Population Health, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Yogyakarta, 55284, Indonesia.ORCID https://orcid.org/0000-0001-9340-3922

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug resistanceIndonesiamedication adherencem-healthsmartphonetuberculosis

Identifiers

PMID39234577
PMCPMC11372341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.